Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · IEX Real-Time Price · USD
4.050
-0.050 (-1.22%)
At close: Mar 28, 2024, 4:00 PM
3.910
-0.140 (-3.46%)
After-hours: Mar 28, 2024, 6:57 PM EDT

Acumen Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019
Net Income
-52.37-42.86-100.61-7.33-7.69
Depreciation & Amortization
0.180.17000
Share-Based Compensation
6.153.060.920.150.17
Other Operating Activities
2.984.4781.72-0.280.92
Operating Cash Flow
-43.06-35.15-17.96-7.45-6.82
Capital Expenditures
-0.02-0.16-0.0400
Change in Investments
-171.6539.35-104.0800
Investing Cash Flow
-171.6739.19-104.1200
Share Issuance / Repurchase
122.233.91169.1900.01
Debt Issued / Paid
29.520000
Other Financing Activities
--31.2844.686.23
Financing Cash Flow
151.753.91200.4744.686.24
Net Cash Flow
-62.987.9478.3937.23-0.58
Free Cash Flow
-43.08-35.31-18-7.45-6.82
Free Cash Flow Per Share
-0.89-0.87-0.90-17.77-15.83
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).